KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) Amortizatization of Intangibles (2012 - 2026)

AbbVie (ABBV) reported Amortizatization of Intangibles of $1.7 billion for Q1 2026, down 8.5% year-over-year from $1.9 billion in Q1 2025, and down 4.33% on a QoQ basis from $1.8 billion in Q4 2025.

AbbVie (ABBV) has 15 years of Amortizatization of Intangibles data on file, last reported at $1.7 billion in Q1 2026.

  • Quarterly Amortizatization of Intangibles fell 8.5% year-over-year to $1.7 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.3 billion (down 3.39% YoY) and the FY2025 annual result came in at $7.4 billion, down 2.93% from the prior year.
  • Amortizatization of Intangibles slipped to $1.7 billion in Q1 2026 per ABBV's latest filing, from $1.8 billion in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $2.1 billion in Q2 2023 and bottomed at $1.7 billion in Q1 2026.
  • The 5-year median for Amortizatization of Intangibles is $1.9 billion (2024), against an average of $1.9 billion.
  • The widest annual swing landed in 2022, when Amortizatization of Intangibles retreated 10.0%; it then grew 16.67% in 2023.
  • Tracing ABBV's Amortizatization of Intangibles over 5 years: stood at $2.0 billion in 2022, then fell by 7.85% to $1.8 billion in 2023, then climbed by 1.68% to $1.9 billion in 2024, then decreased by 5.18% to $1.8 billion in 2025, then decreased by 4.33% to $1.7 billion in 2026.
  • Per Business Quant, the three latest ABBV Amortizatization of Intangibles figures stand at $1.7 billion (Q1 2026), $1.8 billion (Q4 2025), and $1.9 billion (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn -
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn -
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn 1.70 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn 931.00 Mn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn -
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 596.00 Mn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn -
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn -
10 Gsk 88.34 Bn 83.66 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.70 Bn
Mar 31, 2026 1.70 Bn
Dec 31, 2025 1.78 Bn
Dec 31, 2025 1.78 Bn
Sep 30, 2025 1.90 Bn
Sep 30, 2025 1.90 Bn
Jun 30, 2025 1.90 Bn
Jun 30, 2025 1.90 Bn
Mar 31, 2025 1.86 Bn
Mar 31, 2025 1.86 Bn
Dec 31, 2024 1.87 Bn
Dec 31, 2024 1.87 Bn
Sep 30, 2024 1.90 Bn
Sep 30, 2024 1.90 Bn
Jun 30, 2024 1.90 Bn
Jun 30, 2024 1.90 Bn
Mar 31, 2024 1.90 Bn
Mar 31, 2024 1.90 Bn
Dec 31, 2023 1.84 Bn
Dec 31, 2023 1.84 Bn
Sep 30, 2023 2.00 Bn
Sep 30, 2023 2.00 Bn
Jun 30, 2023 2.10 Bn
Jun 30, 2023 2.10 Bn
Mar 31, 2023 1.95 Bn
Mar 31, 2023 1.95 Bn
Dec 31, 2022 2.00 Bn
Dec 31, 2022 2.00 Bn
Sep 30, 2022 2.00 Bn
Sep 30, 2022 2.00 Bn
Jun 30, 2022 1.80 Bn
Jun 30, 2022 1.80 Bn
Mar 31, 2022 1.86 Bn
Mar 31, 2022 1.86 Bn
Dec 31, 2021 1.80 Bn
Dec 31, 2021 1.80 Bn
Sep 30, 2021 1.90 Bn
Sep 30, 2021 1.90 Bn
Jun 30, 2021 2.00 Bn
Jun 30, 2021 2.00 Bn
Mar 31, 2021 2.01 Bn
Mar 31, 2021 2.01 Bn
Dec 31, 2020 4.00 Bn
Dec 31, 2020 4.00 Bn
Sep 30, 2020 2.10 Bn
Sep 30, 2020 2.10 Bn
Jun 30, 2020 1.40 Bn
Jun 30, 2020 1.40 Bn
Mar 31, 2020 444.00 Mn
Mar 31, 2020 444.00 Mn
Dec 31, 2019 353.00 Mn
Dec 31, 2019 353.00 Mn
Sep 30, 2019 389.00 Mn
Sep 30, 2019 389.00 Mn
Jun 30, 2019 388.00 Mn
Jun 30, 2019 388.00 Mn
Mar 31, 2019 385.00 Mn
Mar 31, 2019 385.00 Mn
Dec 31, 2018 326.00 Mn
Dec 31, 2018 326.00 Mn
Sep 30, 2018 320.00 Mn
Sep 30, 2018 320.00 Mn
Jun 30, 2018 324.00 Mn
Jun 30, 2018 324.00 Mn
Mar 31, 2018 330.00 Mn
Mar 31, 2018 330.00 Mn
Dec 31, 2017 292.00 Mn
Dec 31, 2017 292.00 Mn
Sep 30, 2017 268.00 Mn
Sep 30, 2017 268.00 Mn
Jun 30, 2017 269.00 Mn
Jun 30, 2017 269.00 Mn
Mar 31, 2017 271.00 Mn
Mar 31, 2017 271.00 Mn
Dec 31, 2016 210.00 Mn
Dec 31, 2016 210.00 Mn
Sep 30, 2016 208.00 Mn
Sep 30, 2016 208.00 Mn
Jun 30, 2016 181.00 Mn
Jun 30, 2016 181.00 Mn
Mar 31, 2016 165.00 Mn
Mar 31, 2016 165.00 Mn
Dec 31, 2015 140.00 Mn
Dec 31, 2015 140.00 Mn
Sep 30, 2015 125.00 Mn
Sep 30, 2015 125.00 Mn
Jun 30, 2015 86.00 Mn
Jun 30, 2015 86.00 Mn
Mar 31, 2015 68.00 Mn
Mar 31, 2015 68.00 Mn
Dec 31, 2014 96.00 Mn
Dec 31, 2014 96.00 Mn
Sep 30, 2014 98.00 Mn
Sep 30, 2014 98.00 Mn
Jun 30, 2014 99.00 Mn
Jun 30, 2014 99.00 Mn
Mar 31, 2014 110.00 Mn
Mar 31, 2014 110.00 Mn
Dec 31, 2013 101.00 Mn
Dec 31, 2013 101.00 Mn
Sep 30, 2013 137.00 Mn
Sep 30, 2013 137.00 Mn
Jun 30, 2013 136.00 Mn
Jun 30, 2013 136.00 Mn
Mar 31, 2013 135.00 Mn
Mar 31, 2013 135.00 Mn
Dec 31, 2012 136.00 Mn
Dec 31, 2012 136.00 Mn
Sep 30, 2012 134.00 Mn
Sep 30, 2012 134.00 Mn
Jun 30, 2012 176.00 Mn
Jun 30, 2012 176.00 Mn
Mar 31, 2012 179.00 Mn
Mar 31, 2012 179.00 Mn